Raphael Del Roio Liberatore

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith et al. · The Lancet Diabetes & Endocrinology · 2023 · 98 citations · Full text

Metabolic Syndrome, Diabetes Management, Young People +11

Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus

Raphael Del Roio Liberatore, S. F. C. Barbosa, Maria das Gracas Alkimin et al. · Pediatric Diabetes · 2005 · 58 citations

Children With Type 1 Diabetes Mellitus: Self‐Management Experiences in School

Valéria de Cássia Sparapani, Raphael Del Roio Liberatore, Elaine Buchhorn Cintra Damião et al. · Journal of School Health · 2017 · 44 citations

Binge Eating Disorder and body image perception among university students

Marina G. Nicoli, Raphael Del Roio Liberatore · Eating Behaviors · 2011 · 42 citations

Obesity, Bulimia Nervosa, Behavioral Sciences +9

Continuous Subcutaneous Insulin Infusion Pump Treatment in Children with Type 1 Diabetes Mellitus

Raphael Del Roio Liberatore, Kusiel Perlman, Jennifer Buccino et al. · Journal of Pediatric Endocrinology and Metabolism · 2004 · 30 citations

Type 1, Pump Therapy, Diabetes Management +9